Transcatheter Valve Replacement in Adults With Congenital Heart Disease-The Mayo Clinic Experience.

ABSTRACT:

Background

The current study aims to describe outcomes after transcatheter valve replacement in adults with congenital heart disease.

Methods

Retrospective study of adults with congenital heart disease who underwent transcatheter valve replacement and had a 1-year follow-up postintervention at Mayo Clinic (2010-2024). The study period was divided into early (2010-2014), mid (2015-2019), and late (2020-2024) eras. The primary outcome was valve reintervention. The secondary outcomes were all-cause mortality and temporal change in prosthetic valve gradient and clinical indices of disease severity.

Results

Overall, 341 patients (age 38±17 years; 175 [51%] men) received 346 prostheses (pulmonary [N=236, 68%], tricuspid [N=75, 22%], aortic [N=22, 8%], and mitral [N=7, 2%]).

SUBMITTER: Egbe AC 

PROVIDER: S-EPMC12667561 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature